Managed Care Pharmacy Issues

From the AMCP Policy Digest, AMCP's policies regarding pharmacy technicians.

From the AMCP Policy Digest, AMCP's policies regarding access to patient information.

From the AMCP Policy Digest, AMCP's policies regarding Medicaid issues.

From the AMCP Policy Digest, AMCP's policies regarding education, curriculum, and training programs.

From the AMCP Policy Digest, AMCP's policies regarding product packaging and labeling.

From the AMCP Policy Digest, AMCP's policies regarding the audit process.

From the AMCP Policy Digest, AMCP's policies regarding medication safety.

From the AMCP Policy Digest, AMCP's policies regarding ethics issues.

Recognizing the widespread and devastating nature of the opioid crisis, AMCP formed the Addiction Treatment Advisory Group in 2015 based on the recommendation from the AMCP Partnership Forum, Breaking the Link between Pain Management and Opioid Use Disorder.

AMCP CEO Blog: We live in an interconnected world where the marketplace for all things is global. But we must also make sure the global system works for the benefit of the patients we serve. That includes taking steps to ensure the long-term stability and integrity of our critical pharmaceutical supply chain.

Drug utilization review (DUR) is defined as an authorized, structured, ongoing review of prescribing, dispensing and use of medication. DUR encompasses a drug review against predetermined criteria that results in changes to drug therapy when these criteria are not met.

E-prescribing is the use of health care technology to improve prescription accuracy, increase patient safety, and reduce costs as well as enable secure, real-time, bi-directional, electronic connectivity between clinicians and pharmacies. This is achieved by providing prescribers with a secure means of electronically accessing health plan formulary, patient eligibility, and medication history at the point of care and securely transmitting the prescription electronically into the pharmacy’s computer system.